Press Releases

PRESS RELEASES
05/30/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of bio-based pest management and plant health products for the agriculture, turf and ornamental and water treatment markets, announced today that it will be presenting at the 7 th Annual LD Micro
05/11/17
First Quarter GAAP Revenues Increase 56% to $4.2 million First Quarter Product Shipments Increase 66% to Record Level of $6.5 million Closes Secondary Offering and Working Capital Line DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (the "Company" or "we") (NASDAQ:MBII), a leading
05/11/17

MBI to market Jet-Ag fungicide/bactericide to help growers combat plant disease and control bacteria, mold and yeasts

05/09/17

Partnership to help growers in the large and growing export market control pests, improve plant health, and increase crop yields while delivering economic and environmental value

05/04/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ: MBII), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that it will release its earnings results for the first quarter ended March 31, 2017 on
04/28/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ:MBII or "the Company"), today announced the closing of its previously announced underwritten public offering of registered shares of its common stock for gross proceeds of approximately $9.2 million , which includes the full
04/25/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ:MBII or "the Company"), today announced the pricing of its previously announced underwritten public offering. The Company is offering 5,714,286 registered shares of its common stock, par value $0.00001 per share, at a price to
04/24/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ: MBII or "the Company"), today announced that it is proposing to offer shares of its common stock in an underwritten public offering. The Company expects to grant the underwriter a 45-day option to purchase up to an additional
04/06/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (MBI), (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products for the agriculture and water treatment markets, in conjunction with Western Farm Press , is conducting a webinar on walnut pest
03/29/17
Revenues Increase 41% in the Fourth Quarter, up 43% for Full Year Product Shipments Up 102% to $5.2 Million in the Fourth Quarter, up 81% for 2016 to $16.4 Million Full Year Operating Expenses Reduced by 29.6% DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc.
03/28/17
DAVIS, Calif. & REHOVOT, Israel --(BUSINESS WIRE)-- Marrone Bio Innovations Inc. (MBI), (NASDAQ:MBII), a leading global provider of bio-based pest management and plant health products, and Evogene Ltd. (NASDAQ, TASE: EVGN), a leading company for the improvement of crop productivity and economics
03/22/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations, Inc. (NASDAQ:MBII), a leading provider of effective and environmentally responsible pest management and plant health products, announced today that it will release its earnings results for the fourth quarter and full year ended December 31,
02/21/17

23 Academics, Growers and Distributors from Central Florida's Major Agricultural Production Area Gathered to Learn More about Managing Nematodes

01/30/17
DAVIS, Calif. --(BUSINESS WIRE)-- Marrone Bio Innovations (MBI), Inc. (NASDAQ:MBII) and Nufarm Australia Limited announced today the signing of a commercial agreement to develop GRANDEVO ® Bioinsecticide, with Nufarm to be the exclusive distributor in Australia and New Zealand (ANZ).